by CytoPrevent | Feb 2, 2021 | Guidelines & Regulations
Préambule : Ces recommandations concernent les dispositifs médicaux destinés à la préparation et à l’administration parentérale des médicaments cytotoxiques et par extension à tout médicament présentant des risques toxiques pour le personnel et l’environnement....
by CytoPrevent | Feb 1, 2021 | Guidelines & Regulations
The ASSTAS Preamble: In September 2004, the United States National Institute for Occupational Safety and Health (NIOSH) published an alert recommending more stringent preventive measures for the preparation and handling of hazardous drugs. This document quickly...
by CytoPrevent | Jan 25, 2021 | Guidelines & Regulations
Background “The EU needs to address more effectively the impact of the interaction of Occupational Health and Safety (OHS) with the environment and chemicals”, highlighted the European Commission in the results of the evaluation of the 2007-12 OHS strategy. This...
by CytoPrevent | Jan 12, 2021 | Guidelines & Regulations
Allison Field, James Henderson, Ann Hogan, Emma Thoms, Nyasha Manomano, Sue Renn, Alison Simons, Samantha Toland Abstract: This document provides guidance on the handling of cytotoxic chemotherapy and its focus is on traditional small molecule chemotherapy...